Nanoplastics and Neurodegeneration in ALS

Plastic production, which exceeds one million tons per year, is of global concern. The constituent low-density polymers enable spread over large distances and micro/nano particles (MNPLs) induce organ toxicity via digestion, inhalation, and skin contact. Particles have been documented in all human t...

Full description

Bibliographic Details
Published in:	Brain Sciences
Main Authors:	Andrew Eisen, Erik P. Pioro, Stephen A. Goutman, Matthew C. Kiernan
Format:	Article
Language:	English
Published:	MDPI AG 2024-05-01
Subjects:	ALS micro/nanoplastics exposome gut–brain axis TDP-43
Online Access:	https://www.mdpi.com/2076-3425/14/5/471

Similar Items

Codon-optimized TDP-43 mediates neurodegeneration in a Drosophila model of ALS/FTLD
by: Tanzeen Yusuff, et al.
Published: (2023-03-01)

Mechanisms underlying TDP-43 pathology and neurodegeneration: An updated Mini-Review
by: Benjamin I. Nilaver, et al.
Published: (2023-03-01)

Alternative 3′ UTR polyadenylation is disrupted in the rNLS8 mouse model of ALS/FTLD
by: Randall J. Eck, et al.
Published: (2025-01-01)

The Role of TAR DNA Binding Protein 43 (TDP-43) as a CandiDate Biomarker of Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis
by: Caterina Maria Gambino, et al.
Published: (2023-01-01)

TDP-43-M323K causes abnormal brain development and progressive cognitive and motor deficits associated with mislocalised and increased levels of TDP-43
by: Juan M. Godoy-Corchuelo, et al.
Published: (2024-04-01)

Optogenetic TDP-43 nucleation induces persistent insoluble species and progressive motor dysfunction in vivo
by: Charlton G. Otte, et al.
Published: (2020-12-01)

Spliceosome integrity is defective in the motor neuron diseases ALS and SMA
by: Hitomi Tsuiji, et al.
Published: (2013-01-01)

Rapid and inducible mislocalization of endogenous TDP43 in a novel human model of amyotrophic lateral sclerosis
by: Johanna Ganssauge, et al.
Published: (2025-07-01)

The role of adiponectin-AMPK axis in TDP-43 mislocalization and disease severity in ALS
by: Yu-Ju Liu, et al.
Published: (2024-11-01)

Targeting the TDP-43 low complexity domain blocks spreading of pathology in a mouse model of ALS/FTD
by: Elodie Chevalier, et al.
Published: (2024-10-01)

Optineurin knock-out forms TDP-43 aggregates to regulate TDP-43 protein levels despite autophagic up-regulation and aberrant TDP-43 expression
by: Yuta Maetani, et al.
Published: (2025-07-01)

Conditioned Medium from Cells Overexpressing TDP-43 Alters the Metabolome of Recipient Cells
by: Rudolf Hergesheimer, et al.
Published: (2020-09-01)

Synergistic Toxicity of Combined Exposure to Acrylamide and Polystyrene Nanoplastics on the Gut–Liver Axis in Mice
by: Yongchuang Liu, et al.
Published: (2025-05-01)

Prion-like Spreading of Disease in TDP-43 Proteinopathies
by: Emma Pongrácová, et al.
Published: (2024-11-01)

Copper toxicity and deficiency: the vicious cycle at the core of protein aggregation in ALS
by: Jin-Hong Min, et al.
Published: (2024-07-01)

Analysis of asymptomatic Drosophila models for ALS and SMA reveals convergent impact on functional protein complexes linked to neuro-muscular degeneration
by: Marina L. Garcia-Vaquero, et al.
Published: (2023-09-01)

Human Exposures to Micro- and Nanoplastics in Water and Data Needed to Understand Potential Health Effects—A-State of the Science Review
by: Max Zarate-Bermudez, et al.
Published: (2025-09-01)

DNA Damage, Defective DNA Repair, and Neurodegeneration in Amyotrophic Lateral Sclerosis
by: Anna Konopka, et al.
Published: (2022-04-01)

From exposure to neurotoxicity induced by micro-nanoplastics with brain accumulation and cognitive decline
by: Hai-Tao Gao, et al.
Published: (2025-10-01)

Propionic acid/FBP1 is involved in polystyrene nanoplastic-induced cardiac injury via the gut-heart axis
by: Huiwen Kang, et al.
Published: (2025-05-01)

Loss of function of VCP/TER94 causes neurodegeneration
by: Kohei Tsumaki, et al.
Published: (2024-12-01)

Mis-localization of endogenous TDP-43 leads to ALS-like early-stage metabolic dysfunction and progressive motor deficits
by: Yiying Hu, et al.
Published: (2024-06-01)

Modelling TDP-43 proteinopathy in Drosophila uncovers shared and neuron-specific targets across ALS and FTD relevant circuits
by: R. Keating Godfrey, et al.
Published: (2023-10-01)

The Enclosed Intestinal Microbiome: Semiochemical Signals from the Precambrian and Their Disruption by Heavy Metal Pollution
by: David Smith, et al.
Published: (2022-02-01)

Cryptic Splicing of GAP43 mRNA is a Novel Hallmark of TDP‐43‐Associated ALS and AD
by: Mingming Yang, et al.
Published: (2025-09-01)

Traumatic brain injury induces TDP-43 mislocalization and neurodegenerative effects in tissue distal to the primary injury site in a non-transgenic mouse
by: George R. Bjorklund, et al.
Published: (2023-08-01)

The Dying Forward Hypothesis of ALS: Tracing Its History
by: Andrew Eisen
Published: (2021-02-01)

Mature iPSC-derived astrocytes of an ALS/FTD patient carrying the TDP43A90V mutation display a mild reactive state and release polyP toxic to motoneurons
by: Fabiola Rojas, et al.
Published: (2023-07-01)

Integrating gut microbiome and neuroplasticity genomics in alcohol use disorder therapy
by: Ilias Koutromanos, et al.
Published: (2025-07-01)

Lycorine protects motor neurons against TDP-43 proteinopathy-induced degeneration in cross-species models with amyotrophic lateral sclerosis
by: Jing Wen, et al.
Published: (2024-12-01)

TDP-43 Secretion via Extracellular Vesicles Is Regulated by Macroautophagy
by: Yoshinori Tanaka, et al.
Published: (2024-12-01)

A stress-dependent TDP-43 SUMOylation program preserves neuronal function
by: Terry R. Suk, et al.
Published: (2025-03-01)

Development of a Sensitive and Reliable Meso Scale Discovery-Based Electrochemiluminescence Immunoassay to Quantify TDP-43 in Human Biofluids
by: Jiyan An, et al.
Published: (2024-11-01)

TDP-43-Mediated Toxicity in HEK293T Cells: A Fast and Reproducible Protocol To Be Employed in the Search of New Therapeutic Options against Amyotrophic Lateral Sclerosis
by: Débora Lanznaster, et al.
Published: (2019-12-01)

TDP-43 and HERV-K Envelope-Specific Immunogenic Epitopes Are Recognized in ALS Patients
by: Elena Rita Simula, et al.
Published: (2021-11-01)

Alterations in stress granule dynamics driven by TDP-43 and FUS: A link to pathological inclusions in ALS?
by: Anais eAulas, et al.
Published: (2015-10-01)

Novel in vivo TDP-43 stress reporter models to accelerate drug development in ALS
by: Febe Ferro, et al.
Published: (2024-10-01)

Impact of Micro- and Nanoplastics on Mitochondria
by: Seung Eun Lee, et al.
Published: (2022-09-01)

Plasminogen degrades α-synuclein, Tau and TDP-43 and decreases dopaminergic neurodegeneration in mouse models of Parkinson’s disease
by: Chunying Guo, et al.
Published: (2024-04-01)

TDP-43 pathology is associated with divergent protein profiles in ALS brain and spinal cord
by: Emily Feneberg, et al.
Published: (2025-08-01)